Clinical Trials
Study Title:
Phase II Trial of Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma
For more information about the trial above please contact the study team:
Medical University of South Carolina Principal Investigator, Jacqueline Kraveka, at kravekjm@musc.edu. Study Coordinator, Hannah Kinder, at kinderh@musc.edu.
Trial opened at the following institutions: Medical University of South Carolina |